Medical Health & Life Science Research News

Europe's plasma protein therapeutics market will reach USD 6.37 billion in coming years just published

Medical Market Research

Europe Plasma Protein Therapeutics Market by product type, by application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency and others) and by region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

- Advertisement -

According to the report Europe Plasma Protein Therapeutics Market published by Market Data Forecast, the global market is projected to reach USD 6.37 Billion by 2021, at a CAGR of 7.6% from 2016 to 2021.

Plasma is a protein rich fluid which is responsible for blood clotting and providing immunity towards diseases. Isolation of these proteins from plasma can be helpful to provide medical therapies which includes immune deficiencies, autoimmune, neurological and bleeding disorders.

Plasma protein therapies helps in replacing the deficient or missing proteins and helps the individual to lead a normal life.

- Advertisement -
The therapies involves either the injection or infusion of the biological medicines as a treatment to life-threatening genetic and chronic diseases.

Get a comprehensive overview of the Europe Plasma Protein Therapeutics Market:…utics-market-237/ Make an Inquiry about this news

The usage of plasma proteins have increased significantly in the medical application owing to the new introductions in plasma-derived therapies. The advancements in technology has made the process of extracting protein from plasma more efficient and cost saving and is aiding the growth of the market.

WHO reports indicates that more than half of the blood donors are from high income nations which accounts only for 18% of the population. Government initiatives and increasing awareness regarding the blood donations is believed to help the growth of the market

Europe Plasma Protein Therapeutics market: Drivers & Restraints

The market is driven by a host of factors which include increased introduction of new plasma-derived therapies, rise in life threatening diseases which involves immune and neurological systems like chronic inflammatory demyelinating polyneuropathy (CIPD), Ideopathic thrombocytopenic purpura (ITP) and infectious diseases like Hepatitis A&B, Tetanus, Rabies and varicella. However, factors like stringent policies by the government, complexity in manufacturing the proteins reimbursement must be taken care of in order for the market to prosper in the future.

Get accurate market forecast and analysis on the Europe Plasma Protein Therapeutics market. Request a sample to stay up-to-date on the main trends affecting this market…37/request-sample Make an Inquiry about this news

Europe Plasma Protein Therapeutics market: Segmentation

By Type                      

  • Immunoglobulins                                                
  • Albumin                                                  
  • Coagulation Factors                                                            
  • Alpha-1 proteinase inhibitor                                                           
  • Others                                                     

By Application                                                                          

  • Hemophilia                                                             
  • Primary Immunodeficiency Disorder                                                          
  • Idiopathic Thrombocytopenic Purpura                                                       
  • Secondary Immunodeficiency                                                       
  • Others                            

From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information. Get report at…/customize-report Make an Inquiry about this news

Europe Plasma Protein Therapeutics market: Overview

On the basis of product, more than half of the market share was captured by immunoglobulins. Owing to the steep rise in the usage of the immunoglobulins in the treatment of rare diseases including genetic diseases, the demand is expected to grow substantially over the next seven years.

Increasing prevalence of diseases such as primary and secondary immune deficiencies, and other infectious diseases such as rabies is expected to drive the demand for the IgG proteins and boost the market growth. Growing prices of the products owing to the sophisticated procedures such as highly selective affinity chromatography is supposed to fuel the market growth during the forecast period.

Coagulation factors market is expected to a lucrative growth during the forecast period

Europe Plasma Protein Therapeutics market: Region-wise Outlook

On the basis of geography, Europe market is segmented in to United Kingdom, Germany, Italy, France, Spain and others. In Europe, Germany, France and the U.K.

covers the major share of Plasma Protein Therapeutics Market.

Key Questions Answered

  • What are the major players in this industry and the key strategies adopted by them to sustain and grow in the studied Europe market?
  • What is the current and future Plasma Protein Therapeutics Market outlook in Europe? What trends are affecting the Global market?
  • What is the competitive landscape and market share of major players in the Plasma Protein Therapeutics space in Europe?
  • What are the key, high growth markets that Plasma Protein Therapeutics manufacturers should expand into? Which market segments are growing the fastest?
  • What are the unmet needs with the Plasma Protein Therapeutics currently on the market? How will emerging technologies fulfil these unmet needs?
  • What is physician perception and market outlook of Plasma Protein Therapeutics?
  • What are the challenges and barriers that have hindered widespread adoption of Plasma Protein Therapeutics?

Europe Plasma Protein Therapeutics market: Key Players

The major companies the Plasma Protein Therapeutics industry are Baxter, China Biologics, Grifols, Octopharma, Kedrion, shire Plc., CSL Behring, Biotest and Chengdu Inst. SL Behring is the market leader in the plasma protein therapeutics market, while GRIFOLS, S.A leads the global market for IVIG and Alpha 1 antitrypsin.

Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

Reasons to access Europe Plasma Protein Therapeutics market Report:

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
  • Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
  • A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...

For more information:

Make an Inquiry about this report HERE!